🔵 RESEARCH
Multicenter study backs ultrasound fat fraction for steatosis grading
A European Radiology commentary supports ultrasound-derived fat fraction as a non-invasive method for grading hepatic steatosis in chronic liver disease patients.
Quantitative fat fraction strengthens ultrasound's competitive case against MRI-PDFF and biopsy in the expanding NAFLD/NASH market. Procurement teams gain ammunition on cost-effectiveness, though prospective head-to-head data versus MRI remains the credibility hurdle.
🟡 COMPETITIVE
Esaote updates open MRI system for intraoperative brain tumor imaging
Esaote presented a development update on its open MRI platform designed to provide real-time imaging during brain tumor resection.
Esaote is targeting Medtronic's surgical navigation stronghold with an open-architecture pitch in high-margin neurosurgery. Without comparative outcomes data or surgical robot partnerships, this remains a development milestone — not yet a commercial threat.
🔵 RESEARCH
Laryngeal POCUS validated as vocal fold palsy screening tool
A preliminary prospective cohort study found transcutaneous laryngeal ultrasonography reliable as point-of-care imaging for vocal fold assessment.
ENT becomes the next adjacency for handheld ultrasound vendors like Butterfly and GE, potentially displacing some laryngoscopy workflows in outpatient voice clinics. Sample size and gold-standard comparisons against laryngoscopy still need to scale before adoption follows.
Journal of voice : official journal of the Voice Foundation · 2026-05-05
Read more →
⚪ INDUSTRY
ASE releases new guideline on cardiac ultrasound artifacts
The American Society of Echocardiography published a new guideline addressing recognition and management of artifacts in cardiac ultrasound imaging.
Echo labs need more than a reference document — competency assessments, reporting checklist updates, and tech training drive actual interpretation consistency. Watch for health systems embedding artifact recognition into mandatory QA workflows.
⚪ INDUSTRY
Handheld ultrasound market projected to top $567M by 2035
SNS Insider forecasts the global handheld ultrasound devices market will exceed $566.97 million by 2035, signaling sustained POCUS category growth.
The TAM justifies premiums incumbents have paid for POCUS assets and points to further private-equity rollups of niche manufacturers. But adoption still hinges on credentialing, EHR integration, and CMS reimbursement clarity — not just device economics.
Google News: POCUS point-of-care ultrasound · 2026-05-04
Read more →
🔵 RESEARCH
Deep learning model predicts dental implant esthetic risk from radiographs
Researchers developed and clinically validated a deep learning model that uses radiographic surrogate markers to predict aesthetic risk before implant placement.
Dental AI is moving from diagnosis into procedural outcome prediction, pressuring Carestream, Planmeca, and other incumbents to bundle predictive analytics or face acquisition pressure from AI-native challengers. Practice-management interoperability will gate adoption.
NPJ Digital Medicine · 2026-05-05
Read more → (paywall)
🩺 EDITOR’S TAKE — FOR CLINICIANS
Standardisation is the through-line: ASE's echo artifact guideline and laryngeal POCUS validation expand what bedside scanning can credibly do. Update protocols and competency checklists now — guidelines without QA enforcement won't change interpretation quality.
📊 EDITOR’S TAKE — FOR INVESTORS
Handheld ultrasound's $567M 2035 TAM and adjacency expansion into ENT and hepatology validate the consolidation thesis behind recent POCUS deals. Expect incumbents to keep paying premiums for vertical-specific AI and quantification features versus MRI-based competitors.
🏭 EDITOR’S TAKE — FOR INDUSTRY
OEMs face a clear bifurcation: Esaote chases high-margin intraoperative neurosurgery while ultrasound vendors broaden into liver, larynx, and dental adjacencies. Workflow integration — EHR, credentialing, billing — remains the gating factor on whether TAM forecasts materialise.